Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006163 | purine nucleotide metabolic process | 5 | 12 |
GO:0006164 | purine nucleotide biosynthetic process | 6 | 12 |
GO:0006167 | AMP biosynthetic process | 8 | 11 |
GO:0006188 | IMP biosynthetic process | 8 | 12 |
GO:0006189 | 'de novo' IMP biosynthetic process | 9 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009117 | nucleotide metabolic process | 5 | 12 |
GO:0009123 | nucleoside monophosphate metabolic process | 5 | 12 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 6 | 12 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 6 | 12 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 7 | 12 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 12 |
GO:0009152 | purine ribonucleotide biosynthetic process | 7 | 12 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7 | 12 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 12 |
GO:0009165 | nucleotide biosynthetic process | 6 | 12 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7 | 12 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 8 | 12 |
GO:0009259 | ribonucleotide metabolic process | 5 | 12 |
GO:0009260 | ribonucleotide biosynthetic process | 6 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0018130 | heterocycle biosynthetic process | 4 | 12 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 12 |
GO:0019637 | organophosphate metabolic process | 3 | 12 |
GO:0019693 | ribose phosphate metabolic process | 4 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 12 |
GO:0044208 | 'de novo' AMP biosynthetic process | 9 | 11 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 12 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 12 |
GO:0044281 | small molecule metabolic process | 2 | 12 |
GO:0046033 | AMP metabolic process | 7 | 11 |
GO:0046040 | IMP metabolic process | 7 | 12 |
GO:0046390 | ribose phosphate biosynthetic process | 5 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0072521 | purine-containing compound metabolic process | 4 | 12 |
GO:0072522 | purine-containing compound biosynthetic process | 5 | 12 |
GO:0090407 | organophosphate biosynthetic process | 4 | 12 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 12 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 12 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004018 | N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity | 5 | 12 |
GO:0016829 | lyase activity | 2 | 12 |
GO:0016840 | carbon-nitrogen lyase activity | 3 | 12 |
GO:0016842 | amidine-lyase activity | 4 | 12 |
GO:0070626 | (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity | 5 | 11 |
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 362 | 366 | PF00656 | 0.337 |
CLV_NRD_NRD_1 | 266 | 268 | PF00675 | 0.371 |
CLV_NRD_NRD_1 | 420 | 422 | PF00675 | 0.337 |
CLV_PCSK_FUR_1 | 40 | 44 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.296 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 420 | 422 | PF00082 | 0.337 |
CLV_PCSK_PC1ET2_1 | 42 | 44 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 361 | 365 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 392 | 396 | PF00082 | 0.463 |
CLV_PCSK_SKI1_1 | 432 | 436 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.302 |
DEG_APCC_DBOX_1 | 219 | 227 | PF00400 | 0.510 |
DEG_APCC_DBOX_1 | 460 | 468 | PF00400 | 0.337 |
DOC_CYCLIN_RxL_1 | 388 | 398 | PF00134 | 0.257 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 370 | 376 | PF00134 | 0.458 |
DOC_CYCLIN_yCln2_LP_2 | 372 | 378 | PF00134 | 0.337 |
DOC_MAPK_gen_1 | 59 | 66 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 59 | 66 | PF00069 | 0.496 |
DOC_PP2B_LxvP_1 | 224 | 227 | PF13499 | 0.546 |
DOC_PP2B_LxvP_1 | 372 | 375 | PF13499 | 0.337 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 382 | 386 | PF00917 | 0.326 |
DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.485 |
DOC_WW_Pin1_4 | 32 | 37 | PF00397 | 0.463 |
DOC_WW_Pin1_4 | 465 | 470 | PF00397 | 0.337 |
LIG_14-3-3_CanoR_1 | 267 | 277 | PF00244 | 0.486 |
LIG_14-3-3_CanoR_1 | 49 | 58 | PF00244 | 0.518 |
LIG_14-3-3_CanoR_1 | 83 | 90 | PF00244 | 0.510 |
LIG_14-3-3_CanoR_1 | 94 | 99 | PF00244 | 0.510 |
LIG_Actin_RPEL_3 | 381 | 400 | PF02755 | 0.360 |
LIG_Actin_WH2_2 | 69 | 85 | PF00022 | 0.499 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.757 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.501 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.490 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.496 |
LIG_FHA_1 | 455 | 461 | PF00498 | 0.482 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.375 |
LIG_FHA_2 | 146 | 152 | PF00498 | 0.488 |
LIG_FHA_2 | 270 | 276 | PF00498 | 0.485 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.572 |
LIG_GBD_Chelix_1 | 411 | 419 | PF00786 | 0.337 |
LIG_IRF3_LxIS_1 | 350 | 357 | PF10401 | 0.401 |
LIG_LIR_Apic_2 | 186 | 190 | PF02991 | 0.498 |
LIG_LIR_Apic_2 | 422 | 427 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 139 | 147 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 275 | 283 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 300 | 310 | PF02991 | 0.485 |
LIG_LIR_Gen_1 | 405 | 415 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 468 | 477 | PF02991 | 0.353 |
LIG_LIR_Gen_1 | 53 | 62 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 96 | 106 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 139 | 145 | PF02991 | 0.499 |
LIG_LIR_Nem_3 | 253 | 257 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 260 | 265 | PF02991 | 0.512 |
LIG_LIR_Nem_3 | 275 | 280 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 300 | 305 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 405 | 411 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 468 | 473 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.572 |
LIG_LYPXL_yS_3 | 246 | 249 | PF13949 | 0.485 |
LIG_PCNA_yPIPBox_3 | 387 | 397 | PF02747 | 0.257 |
LIG_Pex14_2 | 254 | 258 | PF04695 | 0.485 |
LIG_PTB_Apo_2 | 26 | 33 | PF02174 | 0.487 |
LIG_PTB_Phospho_1 | 26 | 32 | PF10480 | 0.388 |
LIG_SH2_CRK | 277 | 281 | PF00017 | 0.510 |
LIG_SH2_GRB2like | 277 | 280 | PF00017 | 0.522 |
LIG_SH2_PTP2 | 304 | 307 | PF00017 | 0.590 |
LIG_SH2_STAP1 | 270 | 274 | PF00017 | 0.493 |
LIG_SH2_STAP1 | 277 | 281 | PF00017 | 0.475 |
LIG_SH2_STAT3 | 270 | 273 | PF00017 | 0.510 |
LIG_SH2_STAT3 | 309 | 312 | PF00017 | 0.546 |
LIG_SH2_STAT3 | 60 | 63 | PF00017 | 0.571 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 270 | 273 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 304 | 307 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 309 | 312 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 472 | 475 | PF00017 | 0.403 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.450 |
LIG_SH3_3 | 196 | 202 | PF00018 | 0.485 |
LIG_SUMO_SIM_par_1 | 463 | 468 | PF11976 | 0.347 |
LIG_TRAF2_1 | 5 | 8 | PF00917 | 0.731 |
LIG_TRFH_1 | 32 | 36 | PF08558 | 0.484 |
LIG_UBA3_1 | 176 | 183 | PF00899 | 0.510 |
LIG_UBA3_1 | 222 | 231 | PF00899 | 0.547 |
LIG_UBA3_1 | 293 | 299 | PF00899 | 0.547 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.606 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.738 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.751 |
MOD_CK2_1 | 269 | 275 | PF00069 | 0.485 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.555 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.397 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.291 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.464 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.733 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.646 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.559 |
MOD_N-GLC_1 | 152 | 157 | PF02516 | 0.296 |
MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.384 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.485 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.470 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.590 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.513 |
MOD_NEK2_1 | 340 | 345 | PF00069 | 0.411 |
MOD_NEK2_1 | 363 | 368 | PF00069 | 0.360 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.543 |
MOD_PIKK_1 | 146 | 152 | PF00454 | 0.496 |
MOD_PIKK_1 | 23 | 29 | PF00454 | 0.586 |
MOD_PIKK_1 | 269 | 275 | PF00454 | 0.485 |
MOD_PIKK_1 | 77 | 83 | PF00454 | 0.590 |
MOD_PKA_1 | 42 | 48 | PF00069 | 0.510 |
MOD_PKA_2 | 268 | 274 | PF00069 | 0.574 |
MOD_PKA_2 | 42 | 48 | PF00069 | 0.493 |
MOD_PKA_2 | 93 | 99 | PF00069 | 0.540 |
MOD_PKB_1 | 267 | 275 | PF00069 | 0.590 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.491 |
MOD_Plk_1 | 364 | 370 | PF00069 | 0.326 |
MOD_Plk_1 | 442 | 448 | PF00069 | 0.403 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.547 |
MOD_Plk_2-3 | 454 | 460 | PF00069 | 0.484 |
MOD_Plk_2-3 | 99 | 105 | PF00069 | 0.559 |
MOD_Plk_4 | 289 | 295 | PF00069 | 0.571 |
MOD_Plk_4 | 364 | 370 | PF00069 | 0.339 |
MOD_Plk_4 | 414 | 420 | PF00069 | 0.337 |
MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.485 |
MOD_ProDKin_1 | 32 | 38 | PF00069 | 0.462 |
MOD_ProDKin_1 | 465 | 471 | PF00069 | 0.337 |
MOD_SUMO_rev_2 | 113 | 123 | PF00179 | 0.496 |
MOD_SUMO_rev_2 | 306 | 314 | PF00179 | 0.501 |
TRG_DiLeu_BaEn_3 | 217 | 223 | PF01217 | 0.577 |
TRG_ENDOCYTIC_2 | 246 | 249 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 277 | 280 | PF00928 | 0.460 |
TRG_ENDOCYTIC_2 | 304 | 307 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 428 | 431 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.496 |
TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.571 |
TRG_ER_diArg_1 | 419 | 421 | PF00400 | 0.337 |
TRG_Pf-PMV_PEXEL_1 | 107 | 111 | PF00026 | 0.257 |
TRG_Pf-PMV_PEXEL_1 | 361 | 365 | PF00026 | 0.337 |
TRG_Pf-PMV_PEXEL_1 | 448 | 452 | PF00026 | 0.257 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0H3AL67 | Vibrio cholerae serotype O1 (strain ATCC 39541 / Classical Ogawa 395 / O395) | 49% | 100% |
A0A0N1I0W7 | Leptomonas seymouri | 83% | 100% |
A0A0S4JC64 | Bodo saltans | 70% | 100% |
A0A1X0NMR7 | Trypanosomatidae | 72% | 100% |
A0A3R7N1M2 | Trypanosoma rangeli | 73% | 100% |
A4H3W5 | Leishmania braziliensis | 90% | 100% |
A4HS40 | Leishmania infantum | 96% | 100% |
A5IGB3 | Legionella pneumophila (strain Corby) | 47% | 100% |
A7LBL3 | Leishmania donovani | 96% | 100% |
C9ZY37 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 69% | 100% |
E9AK27 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 99% |
O28041 | Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) | 31% | 100% |
P0AB89 | Escherichia coli (strain K12) | 50% | 100% |
P0AB90 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 50% | 100% |
P12047 | Bacillus subtilis (strain 168) | 26% | 100% |
P44797 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 49% | 100% |
P56468 | Helicobacter pylori (strain ATCC 700392 / 26695) | 26% | 100% |
P57351 | Buchnera aphidicola subsp. Acyrthosiphon pisum (strain APS) | 43% | 100% |
P72478 | Streptococcus mutans serotype c (strain ATCC 700610 / UA159) | 27% | 100% |
Q2FFI7 | Staphylococcus aureus (strain USA300) | 24% | 100% |
Q2G2S0 | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 24% | 100% |
Q2YU66 | Staphylococcus aureus (strain bovine RF122 / ET3-1) | 24% | 100% |
Q49YV3 | Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) | 24% | 100% |
Q4L7M3 | Staphylococcus haemolyticus (strain JCSC1435) | 24% | 100% |
Q54J34 | Dictyostelium discoideum | 56% | 100% |
Q58339 | Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) | 26% | 100% |
Q5HEL4 | Staphylococcus aureus (strain COL) | 24% | 100% |
Q5HN26 | Staphylococcus epidermidis (strain ATCC 35984 / RP62A) | 24% | 100% |
Q5ZXD1 | Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) | 47% | 100% |
Q6G825 | Staphylococcus aureus (strain MSSA476) | 24% | 100% |
Q6GFE9 | Staphylococcus aureus (strain MRSA252) | 24% | 100% |
Q7A0G9 | Staphylococcus aureus (strain MW2) | 24% | 100% |
Q7A4Q3 | Staphylococcus aureus (strain N315) | 24% | 100% |
Q89AM3 | Buchnera aphidicola subsp. Baizongia pistaciae (strain Bp) | 41% | 100% |
Q8CRT6 | Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) | 24% | 100% |
Q8K9Q7 | Buchnera aphidicola subsp. Schizaphis graminum (strain Sg) | 42% | 100% |
Q99SX9 | Staphylococcus aureus (strain Mu50 / ATCC 700699) | 24% | 100% |
Q9I0K9 | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) | 50% | 100% |
Q9RSE6 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 26% | 100% |
Q9X0I0 | Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) | 27% | 100% |
Q9ZKA2 | Helicobacter pylori (strain J99 / ATCC 700824) | 26% | 100% |
V5BE01 | Trypanosoma cruzi | 71% | 100% |